[
  {
    "ts": null,
    "headline": "Medtronic’s Evolut trial outcome could shift US TAVR market",
    "summary": "Evolut showed less bioprosthetic valve dysfunction, prosthetic valve thrombosis and haemodynamic structural valve dysfunction than SAPIEN.",
    "url": "https://finnhub.io/api/news?id=1bc0710dda6b649604ec516fe56321c131ee144a87764406600634c24f169cd0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742493849,
      "headline": "Medtronic’s Evolut trial outcome could shift US TAVR market",
      "id": 133325506,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Evolut showed less bioprosthetic valve dysfunction, prosthetic valve thrombosis and haemodynamic structural valve dysfunction than SAPIEN.",
      "url": "https://finnhub.io/api/news?id=1bc0710dda6b649604ec516fe56321c131ee144a87764406600634c24f169cd0"
    }
  }
]